Kathryn van Wie

Kathryn Van Wie is an accomplished professional with significant experience in commercial strategy and market development within the life sciences sector. Currently serving as SVP of Commercial Strategy and Market Development at CND Life Sciences, Kathryn oversees key initiatives in expanding clinical trial services and market access. Prior roles at CND Life Sciences include VP of Commercial Strategy & Market Development and VP of Strategy & Business Development, focusing on international market establishment for the Syn-One Test. Previous experience at Vertex Pharmaceuticals encompasses roles such as Director of US Marketing, where Kathryn led marketing efforts for a rare disease product, and Chief of Staff for North America Commercial Operations, managing operations and strategic communications. Legal expertise was gained through positions at Reichhold, Inc., and various law firms, culminating in a Juris Doctor degree from the University of North Carolina School of Law and a Bachelor of Arts in Spanish Language and Literature from Auburn University.